Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01405300 · ClinicalTrials.gov registry record · Phase 1
The Effects of Peanuts and Peanut Products on Glucose Control and Vascular Function
A Phase 1 study, sponsored by Penn State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT01405300 is a Phase 1 study that has completed, run by Penn State University. The registered enrollment target is 20 participants.
The verdict
NCT01405300, a Phase 1 study, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
Pilot study data have demonstrated that peanuts ameliorate the postprandial glucose and insulin response when incorporated into an acute high fat/high glucose meal. However, it is unclear whether acute consumption of peanuts can also influence vascular function. This study will therefore evaluate the effects of acute peanut consumption on vascular function, glycemic control, and plasma lipids. The hypothesis is that that addition of peanuts to a high fat/high glucose meal will reduce the production of triglycerides, glucose, and improve endothelial function as measured by flow-mediated dilation (FMD).
Interventions
- DIETARY_SUPPLEMENT Control
- DIETARY_SUPPLEMENT Peanut
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-08 |
| Est. Completion | 2014-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01405300
The ClinicalTrials.gov registry entry for NCT01405300 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT01405300 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01405300 about?
NCT01405300 is a clinical study titled "The Effects of Peanuts and Peanut Products on Glucose Control and Vascular Function". Pilot study data have demonstrated that peanuts ameliorate the postprandial glucose and insulin response when incorporated into an acute high fat/high glucose meal. However, it is unclear whether acute consumption of peanuts can also influence vascular function. This study will therefore evaluate th...
What is the current status of trial NCT01405300?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2011-08. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01405300?
The interventions under investigation include: Control (DIETARY_SUPPLEMENT), Peanut (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01405300?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.